Trial intelligence / Profile preview

Acamprosate for Alcohol Dependence in Family Medicine

NCT00381043Phase 4Completed

Sponsor
University of North Carolina at Chapel Hill
Start
Aug 2006
Primary completion
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in alcohol dependence comparing Acamprosate with Placebo (2 arms). Primary endpoints: % Dropout at 12 weeks and Percent Days Abstinent at 12 weeks. Started Aug 2006; status: completed.

02

Drugs

acamprosate
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT00381043.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00381043.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call